The Daclatasvir/Asunaprevir/Beclabuvir Combination Therapy for Chronic Hepatitis C Patients Experiencing Failure of IFN-Free DAA-Based Therapies

The Daclatasvir/Asunaprevir/Beclabuvir Combination Therapy for Chronic Hepatitis C Patients Experiencing Failure of IFN-Free DAA-Based Therapies

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:OBM Hepatology and Gastroenterology 2019-09, Vol.3 (4), p.1-1
Hauptverfasser: Sato, Ken, Naganuma, Atsushi, Saito, Shuichi, Yamazaki, Yuichi, Kobayashi, Takeshi, Tojima, Hiroki, Horiguchi, Norio, Kakizaki, Satoru, Uraoka, Toshio, Ohnishi, Hiroshi, Okamoto, Hiroaki
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1
container_issue 4
container_start_page 1
container_title OBM Hepatology and Gastroenterology
container_volume 3
creator Sato, Ken
Naganuma, Atsushi
Saito, Shuichi
Yamazaki, Yuichi
Kobayashi, Takeshi
Tojima, Hiroki
Horiguchi, Norio
Kakizaki, Satoru
Uraoka, Toshio
Ohnishi, Hiroshi
Okamoto, Hiroaki
description
doi_str_mv 10.21926/obm.hg.1904041
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_21926_obm_hg_1904041</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_21926_obm_hg_1904041</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_21926_obm_hg_19040413</originalsourceid><addsrcrecordid>eNqVj8FOg0AQhvegiY327HVeAFgolXKkWFIvjYfeNwsOsAnskhkw9i18ZFfDC3iaL__kn8knxHMswyTOk5fI1WPYd2Gcy1Sm8Z3YJPssC_YHmT6ILbOp5S7PDmmeyY34vvYIr7oZ9Kz501BU8GL1RPjLR_R5vXiE0o21sXo2zoKvkJ5u0Dqf9-SsaeCMk1_OhqGEd09oZ4bT14TksTG2g0qbYSEE18JbdQkqQv-4KIKjZvxYbxrkJ3Hf6oFxu85HEVWna3kOGnLMhK2ayIyabiqW6s9XeV_Vd2r13f2_8QMD8GNJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The Daclatasvir/Asunaprevir/Beclabuvir Combination Therapy for Chronic Hepatitis C Patients Experiencing Failure of IFN-Free DAA-Based Therapies</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Sato, Ken ; Naganuma, Atsushi ; Saito, Shuichi ; Yamazaki, Yuichi ; Kobayashi, Takeshi ; Tojima, Hiroki ; Horiguchi, Norio ; Kakizaki, Satoru ; Uraoka, Toshio ; Ohnishi, Hiroshi ; Okamoto, Hiroaki</creator><creatorcontrib>Sato, Ken ; Naganuma, Atsushi ; Saito, Shuichi ; Yamazaki, Yuichi ; Kobayashi, Takeshi ; Tojima, Hiroki ; Horiguchi, Norio ; Kakizaki, Satoru ; Uraoka, Toshio ; Ohnishi, Hiroshi ; Okamoto, Hiroaki ; Department of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan ; Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine, Shimotsuke, Tochigi 329 ‑ 0498, Japan ; Department of Gastroenterology, Public Tomioka General Hospital, 2073-1 Tomioka, Tomioka, Gunma 370-2393, Japan ; Department of Gastroenterology, National Hospital Organization Takasaki General Medical Center, 36 Takamatsu-machi, Takasaki, Gunma 370-0829, Japan ; Department of Hepatology, Heisei Hidaka Clinic, 807-1 Nakao-machi, Takasaki , Gunma 371-0001, Japan ; Department of Gastroenterology, Shibukawa General Medical Center, National Hospital Organization, 383 Shiroi, Shibukawa, Gunma, 377-0204, Japan</creatorcontrib><identifier>ISSN: 2577-5804</identifier><identifier>DOI: 10.21926/obm.hg.1904041</identifier><language>eng</language><ispartof>OBM Hepatology and Gastroenterology, 2019-09, Vol.3 (4), p.1-1</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Sato, Ken</creatorcontrib><creatorcontrib>Naganuma, Atsushi</creatorcontrib><creatorcontrib>Saito, Shuichi</creatorcontrib><creatorcontrib>Yamazaki, Yuichi</creatorcontrib><creatorcontrib>Kobayashi, Takeshi</creatorcontrib><creatorcontrib>Tojima, Hiroki</creatorcontrib><creatorcontrib>Horiguchi, Norio</creatorcontrib><creatorcontrib>Kakizaki, Satoru</creatorcontrib><creatorcontrib>Uraoka, Toshio</creatorcontrib><creatorcontrib>Ohnishi, Hiroshi</creatorcontrib><creatorcontrib>Okamoto, Hiroaki</creatorcontrib><creatorcontrib>Department of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan</creatorcontrib><creatorcontrib>Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine, Shimotsuke, Tochigi 329 ‑ 0498, Japan</creatorcontrib><creatorcontrib>Department of Gastroenterology, Public Tomioka General Hospital, 2073-1 Tomioka, Tomioka, Gunma 370-2393, Japan</creatorcontrib><creatorcontrib>Department of Gastroenterology, National Hospital Organization Takasaki General Medical Center, 36 Takamatsu-machi, Takasaki, Gunma 370-0829, Japan</creatorcontrib><creatorcontrib>Department of Hepatology, Heisei Hidaka Clinic, 807-1 Nakao-machi, Takasaki , Gunma 371-0001, Japan</creatorcontrib><creatorcontrib>Department of Gastroenterology, Shibukawa General Medical Center, National Hospital Organization, 383 Shiroi, Shibukawa, Gunma, 377-0204, Japan</creatorcontrib><title>The Daclatasvir/Asunaprevir/Beclabuvir Combination Therapy for Chronic Hepatitis C Patients Experiencing Failure of IFN-Free DAA-Based Therapies</title><title>OBM Hepatology and Gastroenterology</title><issn>2577-5804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNqVj8FOg0AQhvegiY327HVeAFgolXKkWFIvjYfeNwsOsAnskhkw9i18ZFfDC3iaL__kn8knxHMswyTOk5fI1WPYd2Gcy1Sm8Z3YJPssC_YHmT6ILbOp5S7PDmmeyY34vvYIr7oZ9Kz501BU8GL1RPjLR_R5vXiE0o21sXo2zoKvkJ5u0Dqf9-SsaeCMk1_OhqGEd09oZ4bT14TksTG2g0qbYSEE18JbdQkqQv-4KIKjZvxYbxrkJ3Hf6oFxu85HEVWna3kOGnLMhK2ayIyabiqW6s9XeV_Vd2r13f2_8QMD8GNJ</recordid><startdate>20190929</startdate><enddate>20190929</enddate><creator>Sato, Ken</creator><creator>Naganuma, Atsushi</creator><creator>Saito, Shuichi</creator><creator>Yamazaki, Yuichi</creator><creator>Kobayashi, Takeshi</creator><creator>Tojima, Hiroki</creator><creator>Horiguchi, Norio</creator><creator>Kakizaki, Satoru</creator><creator>Uraoka, Toshio</creator><creator>Ohnishi, Hiroshi</creator><creator>Okamoto, Hiroaki</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20190929</creationdate><title>The Daclatasvir/Asunaprevir/Beclabuvir Combination Therapy for Chronic Hepatitis C Patients Experiencing Failure of IFN-Free DAA-Based Therapies</title><author>Sato, Ken ; Naganuma, Atsushi ; Saito, Shuichi ; Yamazaki, Yuichi ; Kobayashi, Takeshi ; Tojima, Hiroki ; Horiguchi, Norio ; Kakizaki, Satoru ; Uraoka, Toshio ; Ohnishi, Hiroshi ; Okamoto, Hiroaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_21926_obm_hg_19040413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Sato, Ken</creatorcontrib><creatorcontrib>Naganuma, Atsushi</creatorcontrib><creatorcontrib>Saito, Shuichi</creatorcontrib><creatorcontrib>Yamazaki, Yuichi</creatorcontrib><creatorcontrib>Kobayashi, Takeshi</creatorcontrib><creatorcontrib>Tojima, Hiroki</creatorcontrib><creatorcontrib>Horiguchi, Norio</creatorcontrib><creatorcontrib>Kakizaki, Satoru</creatorcontrib><creatorcontrib>Uraoka, Toshio</creatorcontrib><creatorcontrib>Ohnishi, Hiroshi</creatorcontrib><creatorcontrib>Okamoto, Hiroaki</creatorcontrib><creatorcontrib>Department of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan</creatorcontrib><creatorcontrib>Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine, Shimotsuke, Tochigi 329 ‑ 0498, Japan</creatorcontrib><creatorcontrib>Department of Gastroenterology, Public Tomioka General Hospital, 2073-1 Tomioka, Tomioka, Gunma 370-2393, Japan</creatorcontrib><creatorcontrib>Department of Gastroenterology, National Hospital Organization Takasaki General Medical Center, 36 Takamatsu-machi, Takasaki, Gunma 370-0829, Japan</creatorcontrib><creatorcontrib>Department of Hepatology, Heisei Hidaka Clinic, 807-1 Nakao-machi, Takasaki , Gunma 371-0001, Japan</creatorcontrib><creatorcontrib>Department of Gastroenterology, Shibukawa General Medical Center, National Hospital Organization, 383 Shiroi, Shibukawa, Gunma, 377-0204, Japan</creatorcontrib><collection>CrossRef</collection><jtitle>OBM Hepatology and Gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sato, Ken</au><au>Naganuma, Atsushi</au><au>Saito, Shuichi</au><au>Yamazaki, Yuichi</au><au>Kobayashi, Takeshi</au><au>Tojima, Hiroki</au><au>Horiguchi, Norio</au><au>Kakizaki, Satoru</au><au>Uraoka, Toshio</au><au>Ohnishi, Hiroshi</au><au>Okamoto, Hiroaki</au><aucorp>Department of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan</aucorp><aucorp>Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine, Shimotsuke, Tochigi 329 ‑ 0498, Japan</aucorp><aucorp>Department of Gastroenterology, Public Tomioka General Hospital, 2073-1 Tomioka, Tomioka, Gunma 370-2393, Japan</aucorp><aucorp>Department of Gastroenterology, National Hospital Organization Takasaki General Medical Center, 36 Takamatsu-machi, Takasaki, Gunma 370-0829, Japan</aucorp><aucorp>Department of Hepatology, Heisei Hidaka Clinic, 807-1 Nakao-machi, Takasaki , Gunma 371-0001, Japan</aucorp><aucorp>Department of Gastroenterology, Shibukawa General Medical Center, National Hospital Organization, 383 Shiroi, Shibukawa, Gunma, 377-0204, Japan</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Daclatasvir/Asunaprevir/Beclabuvir Combination Therapy for Chronic Hepatitis C Patients Experiencing Failure of IFN-Free DAA-Based Therapies</atitle><jtitle>OBM Hepatology and Gastroenterology</jtitle><date>2019-09-29</date><risdate>2019</risdate><volume>3</volume><issue>4</issue><spage>1</spage><epage>1</epage><pages>1-1</pages><issn>2577-5804</issn><doi>10.21926/obm.hg.1904041</doi></addata></record>
fulltext fulltext
identifier ISSN: 2577-5804
ispartof OBM Hepatology and Gastroenterology, 2019-09, Vol.3 (4), p.1-1
issn 2577-5804
language eng
recordid cdi_crossref_primary_10_21926_obm_hg_1904041
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
title The Daclatasvir/Asunaprevir/Beclabuvir Combination Therapy for Chronic Hepatitis C Patients Experiencing Failure of IFN-Free DAA-Based Therapies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T05%3A02%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Daclatasvir/Asunaprevir/Beclabuvir%20Combination%20Therapy%20for%20Chronic%20Hepatitis%20C%20Patients%20Experiencing%20Failure%20of%20IFN-Free%20DAA-Based%20Therapies&rft.jtitle=OBM%20Hepatology%20and%20Gastroenterology&rft.au=Sato,%20Ken&rft.aucorp=Department%20of%20Gastroenterology%20and%20Hepatology,%20Gunma%20University%20Graduate%20School%20of%20Medicine,%203-39-22%20Showa-machi,%20Maebashi,%20Gunma%20371-8511,%20Japan&rft.date=2019-09-29&rft.volume=3&rft.issue=4&rft.spage=1&rft.epage=1&rft.pages=1-1&rft.issn=2577-5804&rft_id=info:doi/10.21926/obm.hg.1904041&rft_dat=%3Ccrossref%3E10_21926_obm_hg_1904041%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true